SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 584 filers reported holding SEAGEN INC in Q2 2023. The put-call ratio across all filers is 1.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,683,953 | +29.6% | 135,206 | +17.6% | 0.34% | +28.2% |
| Q2 2023 | $22,132,900 | +55.4% | 115,000 | +63.5% | 0.26% | +35.1% |
| Q1 2023 | $14,243,765 | -55.6% | 70,350 | -71.9% | 0.19% | -54.9% |
| Q4 2022 | $32,116,448 | -22.3% | 249,914 | +7.0% | 0.43% | -32.5% |
| Q2 2022 | $41,337,000 | -79.6% | 233,620 | -83.4% | 0.64% | -80.7% |
| Q1 2022 | $202,778,000 | +96.4% | 1,407,693 | +110.7% | 3.29% | +122.6% |
| Q4 2021 | $103,273,000 | +5.3% | 668,004 | +15.6% | 1.48% | -7.7% |
| Q3 2021 | $98,094,000 | +7.6% | 577,704 | +0.0% | 1.60% | -5.8% |
| Q2 2021 | $91,200,000 | +1190.7% | 577,655 | +1035.2% | 1.70% | +983.4% |
| Q1 2021 | $7,066,000 | -19.0% | 50,887 | +2.2% | 0.16% | -32.0% |
| Q4 2020 | $8,721,000 | – | 49,797 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |